Ergoteles’s Vivani Medical VANI Stock Holding History

Ergoteles’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,200	Closed	-$32K	–	2008
2022 Q2	$32K	Buy	+5,200	New	+$28K	﹤0.01%	1573

Other funds holding VANI

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Ergoteles's VANI Position: Q3 2022 in Review

Ergoteles sold out of Vivani Medical (VANI) in Q3 2022, closing a stake of 5,200 shares — an estimated $32K sold.

Ergoteles first reported a position in VANI in Q2 2022 and held it in 1 quarter. The position peaked at $32K in Q2 2022. 28 funds tracked by Wall St. Rank hold VANI as of Q3 2022.

Ergoteles reported no remaining Vivani Medical position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 5,200 Vivani Medical shares in Q3 2022, an estimated $32K.
Ergoteles first reported a position in Vivani Medical in Q2 2022 and held it in 1 quarter.
Ergoteles's Vivani Medical position peaked at $32K in Q2 2022.
28 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.